drugset / Trial / NCT00762658
A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test
RandomizedDouble-blindTreatment
Summary
To investigate dose-response relationship, antipsoriatic efficacy and safety of different concentrations of topical formulations of AN2728 in patients with psoriasis vulgaris
Timeline
- Start
- 2007-11-30
- Primary completion
- 2007-12-07
- Completion
- 2007-12-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Betamethasone | Other / unclassified | 0.1 % | Topical |
| Subject | Crisaborole | Small molecule | 0.5 % | Topical |
| Subject | Crisaborole | Small molecule | 2 % | Topical |
| Subject | Crisaborole | Small molecule | 5 % | Topical |
| Comparator | Tacrolimus | Small molecule | 0.1 % | Topical |